VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
GLUEMonte Rosa Therapeutics, Inc.$17.10$1.1B
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksGLUEPrice History

GLUE logoMonte Rosa Therapeutics, Inc. (GLUE) Stock Price History

Historical prices from 2021 to 2026

$17.10+0.58  (+3.51%)close Jun 11
Returns
1M
-15.6%
3M
+0.2%
YTD
+11.7%
1Y
+238.6%
3Y
+35.7%
5Y
-4.2%
ATH$45.56Sep 2021-62.5%
ATL$2.44Oct 2023pre-split
Avg Vol (50D)809K/ day
52-Week Range$4.12 — $25.77
LowCurrent: $17.10High

Loading 10-year price history...

GLUE Historical Performance

1 YearTotal Return
+238.6%
Price: +238.6%
3 YearsTotal Return
+149.6%
CAGR: +35.7%
Price: +149.6%
5 YearsTotal Return
-19.3%
CAGR: -4.2%
Price: -19.3%
YTD
+11.7%

GLUE Annual Returns

Year-by-year price performance · 2021–2026

Best+120.5%2025
Worst-62.7%2022
Up years3/6
2021-3.6%
2022-62.7%
2023-27.4%
2024+21.5%
2025+120.5%
2026+15.9%
2021 annual price return
-3.6%
2022 annual price return
-62.7%
2023 annual price return
-27.4%
2024 annual price return
+21.5%
2025 annual price return
+120.5%
2026 annual price return
+15.9%
LessMore
Alpha vs S&P 500
1Y+215.9%
3Y+14.7%
5Y-16.5%

Price returns only.

Download Historical Data

1,248 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

GLUE Stock Price Trajectory (2021–2026)

As of June 12, 2026, Monte Rosa Therapeutics, Inc. (GLUE) trades at $17.10, representing a +238.6% return over the past year. The stock has delivered a -19.3% total return over five years (-4.2% CAGR), reflecting challenging market conditions.

The stock reached its all-time high of $45.56 on September 7, 2021. From this peak, GLUE has corrected -62.5%, currently trading 10% above its 200-day moving average, indicating continued institutional support.

When compared to Healthcare sector peers ARVN (-7.6% 1Y), KYMR (+71.4% 1Y), and PRAX (+456.0% 1Y), GLUE has underperformed the peer group average. Compare GLUE vs ARVN →

GLUE Historical Price Data · from 2021

Rows 1–50 of 1,248
Date Open High Low Close Volume Change %
2026-06-1116.5417.3116.3917.101.38M+3.51%
2026-06-1016.9917.2916.2816.52841K-0.54%
2026-06-0917.6817.8316.1516.61818K-2.29%
2026-06-0816.5617.0416.1117.002.01M+3.85%
2026-06-0517.4517.8016.2516.37917K-5.70%
2026-06-0417.4818.0717.0917.36707K-1.31%
2026-06-0317.8718.0217.3017.59882K-0.85%
2026-06-0219.2719.3817.7217.74972K-9.81%
2026-06-0119.7519.8618.6319.67976K-0.20%
2026-05-2919.8720.3619.2319.711.01M+1.65%
2026-05-2819.2019.5518.8819.391.17M+1.15%
2026-05-2719.3320.1119.0819.17553K-0.16%
2026-05-2619.1019.5818.8319.20659K+2.07%
2026-05-2218.7218.8118.4518.81857K-0.37%
2026-05-2118.0119.1617.8918.88718K+1.23%
2026-05-2017.9318.9617.8118.65879K+6.09%
2026-05-1917.9518.0217.4417.58617K-2.39%
2026-05-1818.3318.5717.6718.01568K-0.77%
2026-05-1518.4618.5417.9318.15916K-2.84%
2026-05-1418.9819.1618.6018.68451K-1.48%
2026-05-1318.8419.0818.6218.96662K-0.78%
2026-05-1219.8820.0219.0019.11505K-5.68%
2026-05-1119.7721.2719.6420.26972K+4.49%
2026-05-0820.1120.1119.1619.39525K-2.12%
2026-05-0720.2520.3019.2419.81656K-2.84%
2026-05-0619.4720.7219.1220.391.08M+5.37%
2026-05-0519.8119.9718.8319.35536K-1.12%
2026-05-0418.8119.8918.7619.57732K+4.10%
2026-05-0119.0419.4418.6618.80624K-1.83%
2026-04-3019.1319.2118.7119.15451K+2.30%
2026-04-2918.7719.0418.5018.72517K-1.53%
2026-04-2819.1619.8518.6819.01571K-1.45%
2026-04-2720.2520.2519.0419.29464K-2.53%
2026-04-2420.2320.4519.4419.79525K-1.88%
2026-04-2320.8721.2319.6620.17816K-3.86%
2026-04-2221.3021.6220.6120.981.05M+0.43%
2026-04-2119.7221.0119.1820.89861K+5.45%
2026-04-2019.7820.1719.3919.811.29M+0.15%
2026-04-1719.1419.9318.7519.78880K+5.78%
2026-04-1618.2018.7218.0518.701.08M+2.58%
2026-04-1517.5318.4717.3518.23928K+4.17%
2026-04-1418.0218.0617.4817.50631K-0.28%
2026-04-1317.4818.5017.4817.55789K+0.40%
2026-04-1018.0818.1417.3917.48694K-3.16%
2026-04-0916.9018.1516.8918.05856K+5.43%
2026-04-0817.6517.9916.9617.121.13M0.00%
2026-04-0716.7217.1416.3417.12428K+1.12%
2026-04-0617.1217.6816.8616.93692K-0.94%
2026-04-0216.8117.8816.6117.091.24M-0.47%
2026-04-0116.7517.2616.3117.172.34M+4.38%
…

What if you invested $1,000 in GLUE 10 years ago?

Total return calculator · dividends reinvested

Calculate Returns

How much would $100/month in GLUE be worth today?

Dollar cost averaging vs lump sum · see how regular investing compounds over time

Run the Numbers

Is GLUE Undervalued Right Now?

DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.

View Valuation

GLUE vs LLY — which is the better buy?

Side-by-side revenue, margins, P/E and 10-year returns vs Eli Lilly and Company.

Compare Now

GLUE — Frequently Asked Questions

Quick answers to the most common questions about buying GLUE stock.

How has GLUE stock performed recently?

GLUE returned +238.6% over the past year, beating its 5-year annualized CAGR of -4.2%. The stock trades above its 200-day moving average, confirming the uptrend.

What is GLUE's all-time high price?

Monte Rosa Therapeutics, Inc. reached $45.56 on 2021-09-07. The 52-week high is $25.77. Current 1-year return of +238.6% places the stock closer to historical peaks.

Where can I download GLUE historical price data?

This page provides GLUE daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2021-2026, downloadable in CSV format.

417 data points · sampled from 1,248